AhR agonist 2 is a triazolopyridine derivative and novel aryl hydrocarbon receptor (AhR) agonist with the advantages of being orally bioavailable and highly potent (EC50=0.03 nM), inducing rapid nuclear enrichment of the AhR and facilitating skin barrier repair for the treatment of psoriasis.
Molekulargewicht:
353.01
Formel:
C12H7Br2N3
Target-Kategorie:
AhR|||Aryl Hydrocarbon Receptor
T61244
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten